Electromagnetic Field, Dysmenorrhea
Conditions
Keywords
Dysmenorrhea, Pulsed electromagnetic field, Diclofenac
Brief summary
Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women
Detailed description
Background: Primary dysmenorrhea is one of the most common complaints of women and is also the most common gynecological problem worldwide. These cramps are recurrent and 90% adolescent girls and about 50% women suffer from it. Purpose of the study: to determine which is more effective in alleviating primary dysmenorrhea; pulsed electromagnetic field or diclofenac drugs. Methodology: The study was a randomized, double-blinded trial, fifty adult females participated in this study, were divided randomly into two groups equal in numbers: group (A) received pulsed electromagnetic field applied on pelvic region, 3 times per week for 3 months, 20 minutes per day and group (B) received diclofenac tablets, 50 mg only with onset of menstrual pain. All participants in both groups (A and B) were assessed pre- and post-treatment through measuring progesterone level in the blood, assessment of pain using visual analogue scale and physical as well as psychological symptoms by using menstrual symptom questionnaire.
Interventions
EASY Qs portable (by ASA, Italy)
DRUGdiclofenac tablets
drugs
DIAGNOSTIC_TESTVisual analogue scale
a graphic rating scale
DIAGNOSTIC_TESTProgesterone blood level
blood test
DIAGNOSTIC_TESTMenstrual symptom questionnaire
questionnaire
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
(Participant, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
17 Years to 24 Years
Healthy volunteers
No
Inclusion criteria
-regular menstrual cycle 21-35 days lasting 3-7 days
Exclusion criteria
* Irregulars or infrequent menstrual cycles, Pacemaker, Myasthenia gravis, hyperthyroidism, active tuberculosis and psychosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual analogue scale | three months | was used to determine the pain intensity level. Pain assessed before and after treatment procedure (3 month); in both groups (A and B) by (16), it is a graphic rating scale with numerical values placed equidistantly along the line. The descriptors and numbers help the subject to place her estimate on line in which (0) mean no pain, (1) equal mild pain, (2) equal moderate pain, (3) mean severe pain and (4) mean unbearable pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Progesterone blood level | three months | Sample of blood was taken to detect the level of progesterone. |
| Menstrual symptom questionnaire | three months | to assess symptoms of dysmenorrhea |
Outcome results
None listed